PARLIAMENTARY WRITTEN QUESTION
Respiratory Syncytial Virus: Vaccination (9 October 2024)

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the public information campaign for RSV vaccination uptake; and what further communication he plans for (a) people over 80 and (b) other ineligible groups.

Asked by:
Dr Ben Spencer (Conservative)

To raise awareness of the potential vaccination benefits and increase awareness of the programmes amongst health professionals, parents, carers, and the wider public, the UK Health Security Agency (UKHSA) provides a comprehensive suite of public facing resources and assets. This includes information leaflets in multiple languages and accessible formats, for instance easy read, British Sign Language, and braille. The UKHSA also provides comprehensive clinical guidance, including e-learning programmes and training for healthcare professionals.

Following the public information campaign, as of 30 September 2024, 663,674 respiratory syncytial virus (RSV) vaccinations have been administered across England since the programme commenced on 1 September 2024. This includes 611,527 vaccines given to the older adult cohort and 39,223 to the maternity cohort. Statistics on the RSV vaccination programme for England will continue to be published weekly, and are available at the following link:

www.england.nhs.uk/statistics/vaccinations-rsv/

Consideration is being given to development and publication of an asset to inform people who are currently not eligible.

Answered by:
Andrew Gwynne (Labour)
17 October 2024